Skip to main content
. 2020 Sep 28;73(9):e3505–e3510. doi: 10.1093/cid/ciaa1444

Table 1.

Comparison of Baseline Demographics, Clinical Features, and Cerebrospinal Fluid Biochemical and Cellular Parameters According to GeneXpert MTB/RIF Ultra Cycle Threshold Tertile Categories

Characteristic Low Tertile (Ct 16.2–20.0) (n = 22) Intermediate Tertile (Ct 20.1–25.0) (n = 24) High Tertile (Ct 25.1–32.7) (n = 24) P Valuea
Baseline demographics
 Age, y 32 (29–36) 34 (32–38) 31 (28–37) .26
 Sex, female 10 (46%) 10 (42%) 7 (29%) .49
HIV details
 HIV positive 20 (91%) 23 (96%) 24 (100%) .31
 Currently on ART 10 (48%) 12 (52%) 13 (54%) .91
 Months on ARTb,c 9.7 (3.1–22.2) 2.3 (0.3–7.0) 1.1 (0.7–3.4) .18
 CD4 countc, cells/μL 58 (48–73) 89 (56–210) 59 (14–117) .36
Clinical details
 Focal neurological deficit 5 (23%) 4 (17%) 10 (42%) .13
 Fever 18 (82%) 19 (79%) 20 (83%) .65
BMRC TBM grade
 1 2 (10%) 5 (21%) 2 (9%) .46
 2 13 (62%) 16 (67%) 14 (61%)
 3 6 (29%) 3 (13%) 7 (30%)
Baseline CSF characteristics
 Total WBC countc, cells/μL 80 (4–245) 35 (4–250) 35 (4–165) .50
 % lymphocytes 95 (65–100) 85 (69–100) 93 (65–100) .92
 Opening pressurec, mm H2O 190 (100–270) 230 (100–290) 205 (130–300) .97
 Proteinc, mg/dL 118 (46–208) 156 (90–316) 144 (101–200) .58
 Lactatec, mmol/L 10.6 (9.5–12.0) 7.6 (6.9–9.5) 7.4 (4.6–9.8) .03
 Glucosec, mg/dL 27 (18–33) 32 (18–70) 30 (21–60) .44

Data are presented as median (interquartile range) or no. (%).

Abbreviations: ART, antiretroviral therapy; BMRC, British Medical Research Council; CSF, cerebrospinal fluid; Ct, Xpert Ultra polymerase chain reaction cycle threshold; HIV, human immunodeficiency virus; TBM, tuberculous meningitis; WBC, white blood cell.

aKruskal-Wallis for medians; χ 2 test for proportions.

bAmong those on ART at diagnosis.

cIncomplete data: months on ART (n = 29); CD4 cell count (n = 41); total WBC count (n = 65); opening pressure (n = 39); CSF protein (n = 60); CSF lactate (n = 31); CSF glucose (n = 54).